Anti-inflammatory effect of metallic silver and gold nanoparticles complexed with polyphenolic compounds in human chronic stationary plaque psoriasis

[1]  Y. H. Lee,et al.  Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis. , 2015, Genetics and molecular research : GMR.

[2]  F. Capon,et al.  Update on psoriasis immunopathogenesis and targeted immunotherapy , 2015, Seminars in Immunopathology.

[3]  P. Rahman,et al.  Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis. , 2015, Rheumatic diseases clinics of North America.

[4]  S. Shetty,et al.  Guidelines for bath PUVA, bathing suit PUVA and soak PUVA. , 2015, Indian Journal of Dermatology, Venereology and Leprology.

[5]  E. Çalışkan,et al.  Narrow band ultraviolet-B versus Goeckerman therapy for psoriasis with and without acitretin: A retrospective study. , 2015, Indian Journal of Dermatology, Venereology and Leprology.

[6]  M. Crisan,et al.  The role of vitamin C in pushing back the boundaries of skin aging: an ultrasonographic approach , 2015, Clinical, cosmetic and investigational dermatology.

[7]  T. Luger,et al.  The skin in psoriasis: assessment and challenges. , 2015, Clinical and experimental rheumatology.

[8]  S. Chimenti,et al.  Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1). , 2015, Journal of the American Academy of Dermatology.

[9]  Anne-Marie Constantin,et al.  VEGF involvement in psoriasis , 2015, Clujul medical.

[10]  T. Gress,et al.  Recognizing Guttate Psoriasis and Initiating Appropriate Treatment. , 2015, West Virginia Medical Journal.

[11]  S. Feldman,et al.  A guide to prescribing home phototherapy for patients with psoriasis: the appropriate patient, the type of unit, the treatment regimen, and the potential obstacles. , 2015, Journal of the American Academy of Dermatology.

[12]  A. Offidani,et al.  Non-alcoholic fatty liver disease and psoriasis: So far, so near. , 2015, World journal of hepatology.

[13]  M. Augustin,et al.  Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic Review , 2015, Dermatology and Therapy.

[14]  Madhu Gupta,et al.  Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis , 2015, Artificial cells, nanomedicine, and biotechnology.

[15]  A. Eggen,et al.  Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences* , 2014, The British journal of dermatology.

[16]  Jürgen Lademann,et al.  Interaction of dermatologically relevant nanoparticles with skin cells and skin , 2014, Beilstein journal of nanotechnology.

[17]  Ximena Wortsman-Cánovas.  Fundamentals and Introduction to Dermatology Sonography , 2014 .

[18]  Sanyog Jain,et al.  Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis , 2014, Expert opinion on drug delivery.

[19]  M. Crisan,et al.  Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract. , 2014, Colloids and surfaces. B, Biointerfaces.

[20]  Ghulam Murtaza,et al.  Gold Nanoparticles: Synthesis and Applications in Drug Delivery , 2014 .

[21]  J. Serup,et al.  High‐frequency ultrasound imaging of tattoo reactions with histopathology as a comparative method. Introduction of preoperative ultrasound diagnostics as a guide to therapeutic intervention , 2014, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[22]  Edward A. Sykes,et al.  Nanoparticle exposure in animals can be visualized in the skin and analyzed via skin biopsy , 2014, Nature Communications.

[23]  S. Azar,et al.  Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis , 2014, Therapeutic Advances in Endocrinology and Metabolism.

[24]  A. Love,et al.  “Green” Nanotechnologies: Synthesis of Metal Nanoparticles Using Plants , 2014, Acta naturae.

[25]  V. Castranova,et al.  Oxidative Stress and Dermal Toxicity of Iron Oxide Nanoparticles In Vitro , 2013, Cell Biochemistry and Biophysics.

[26]  S. Cheng,et al.  Surface functionalized gold nanoparticles for drug delivery. , 2013, Journal of biomedical nanotechnology.

[27]  M. Maître,et al.  Risk of cancer in psoriasis: a systematic review and meta‐analysis of epidemiological studies , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  M. Crisan,et al.  New nanomaterials for the improvement of psoriatic lesions. , 2013, Journal of materials chemistry. B.

[29]  F. Amzica,et al.  Ultrasonographic staging of cutaneous malignant tumors: an ultrasonographic depth index , 2013, Archives of Dermatological Research.

[30]  H. Lang,et al.  Direct detection of a BRAF mutation in total RNA from melanoma cells using cantilever arrays. , 2013, Nature nanotechnology.

[31]  A. Gottlieb,et al.  NF-κB: an essential transcription factor in psoriasis. , 2013, Journal of dermatological science.

[32]  W. Liao,et al.  Phototherapy in Psoriasis: A Review of Mechanisms of Action , 2013, Journal of cutaneous medicine and surgery.

[33]  A. Pietrzak,et al.  Melanoma and other malignant skin cancers in psoriatic patients treated with phototherapy. Role of the p16 protein in psoriasis. , 2012, Folia histochemica et cytobiologica.

[34]  M. D. F. D. de Oliveira,et al.  Psoriasis and uveitis: a literature review , 2012, Anais brasileiros de dermatologia.

[35]  Willy Verstraete,et al.  Biologically produced nanosilver: Current state and future perspectives , 2012, Biotechnology and bioengineering.

[36]  Jürgen Lademann,et al.  Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. , 2012, ACS nano.

[37]  M. Crisan,et al.  Ultrasonographic assessment of skin structure according to age. , 2012, Indian journal of dermatology, venereology and leprology.

[38]  Y. Yoshihisa,et al.  The anti-inflammatory effects of platinum nanoparticles on the lipopolysaccharide-induced inflammatory response in RAW 264.7 macrophages , 2012, Inflammation Research.

[39]  P. Schafer.  Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. , 2012, Biochemical Pharmacology.

[40]  F. Marincola,et al.  The role of BRAF V600 mutation in melanoma , 2012, Journal of Translational Medicine.

[41]  A. Qureshi,et al.  Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. , 2012, American journal of epidemiology.

[42]  C. Cattani,et al.  Imagistic Noninvasive Assessment of Skin Ageing and Anti-Ageing Therapies , 2012 .

[43]  Menaka C Thounaojam,et al.  Cytotoxicity evaluation and antimicrobial studies of starch capped water soluble copper nanoparticles. , 2012, Journal of hazardous materials.

[44]  M. Crisan,et al.  Clinical, Cosmetic and Investigational Dermatology Dovepress Ultrasonographic Assessment of the Cutaneous Changes Induced by Topical Flavonoid Therapy , 2022 .

[45]  D. Skokos,et al.  Th17 Response and Inflammatory Autoimmune Diseases , 2011, International journal of inflammation.

[46]  F. Ayala.  Clinical presentation of psoriasis. , 2011, Reumatismo.

[47]  B. Tang,et al.  Effect of gold nanoparticles on glutathione depletion-induced hydrogen peroxide generation and apoptosis in HL7702 cells. , 2011, Toxicology letters.

[48]  Srikanth K. Iyer,et al.  Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. , 2011, The Journal of clinical investigation.

[49]  Wolfgang Becker,et al.  Nanoparticles and microparticles for skin drug delivery. , 2011, Advanced drug delivery reviews.

[50]  A. Bewley,et al.  What is new in topical therapy for psoriasis? , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[51]  R Kazys,et al.  Principles of high‐frequency ultrasonography for investigation of skin pathology , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[52]  W Sterry,et al.  Penetration and storage of particles in human skin: perspectives and safety aspects. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[53]  Cord Sunderkötter,et al.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.

[54]  A. Menter,et al.  Psoriasis: comorbidities and associations. , 2011, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[55]  M. Pinheiro,et al.  Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis , 2011, Arthritis Research & Therapy.

[56]  A. Aplin,et al.  Paying "particle" attention to novel melanoma treatment strategies. , 2010, The Journal of investigative dermatology.

[57]  Lisa C. Zaba,et al.  A subpopulation of CD163-positive macrophages is classically activated in psoriasis. , 2010, The Journal of investigative dermatology.

[58]  Osamu Yamamoto,et al.  In vivo effect of industrial titanium dioxide nanoparticles experimentally exposed to hairless rat skin , 2010, Nanotoxicology.

[59]  Andrea B Troxel,et al.  The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. , 2010, Archives of dermatology.

[60]  W. Abramovits,et al.  Applications of nanomedicine in dermatology: use of nanoparticles in various therapies and imaging , 2010, Journal of cosmetic dermatology.

[61]  S. Feldman,et al.  Vitamine D analogue-based therapies for psoriasis. , 2010, Drugs of today.

[62]  F. Aubin,et al.  Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[63]  Jinatta Jittiwat,et al.  Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. , 2010, Biomaterials.

[64]  Chun-Ming Huang,et al.  Development of nanoparticles for antimicrobial drug delivery. , 2010, Current medicinal chemistry.

[65]  D. Thaçi,et al.  Treatment of moderate-to-severe plaque psoriasis. , 2009, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[66]  P. Tam,et al.  Further Evidence of the Anti‐inflammatory Effects of Silver Nanoparticles , 2009, ChemMedChem.

[67]  J. Dreiher,et al.  Psoriasis associated with ulcerative colitis and Crohn's disease , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[68]  K. Scharffetter-Kochanek,et al.  Key role of macrophages in the pathogenesis of CD18 hypomorphic murine model of psoriasis. , 2009, The Journal of investigative dermatology.

[69]  Xia Zhang,et al.  Activation of Murine Macrophages , 2008, Current protocols in immunology.

[70]  M. Gilliet,et al.  Antimicrobial peptides and self-DNA in autoimmune skin inflammation. , 2008, Current opinion in immunology.

[71]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. , 2008, Journal of the American Academy of Dermatology.

[72]  P. Sarzi-Puttini,et al.  Autoantibody production in patients treated with anti-TNF-α , 2008, Expert review of clinical immunology.

[73]  D. Ioannides,et al.  Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris , 2008, Therapeutics and clinical risk management.

[74]  M. Murphy,et al.  The histopathologic spectrum of psoriasis. , 2007, Clinics in dermatology.

[75]  I. Mellman,et al.  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.

[76]  A. Menter,et al.  Current and future management of psoriasis , 2007, The Lancet.

[77]  Claus-Michael Lehr,et al.  Nanoparticles--an efficient carrier for drug delivery into the hair follicles. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[78]  A. Gottlieb,et al.  Mechanisms of action of etanercept in psoriasis. , 2007, The journal of investigative dermatology. Symposium proceedings.

[79]  P. Schechter,et al.  Effects of Nanocrystalline Silver (NPI 32101) in a Rat Model of Ulcerative Colitis , 2007, Digestive Diseases and Sciences.

[80]  A. Bõer,et al.  Use of fumaric acid esters in psoriasis. , 2007, Indian journal of dermatology, venereology and leprology.

[81]  M. Roberts,et al.  Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety , 2007, Critical reviews in toxicology.

[82]  R. Clark,et al.  Misbehaving macrophages in the pathogenesis of psoriasis. , 2006, The Journal of clinical investigation.

[83]  M. Pasparakis,et al.  Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. , 2006, The Journal of clinical investigation.

[84]  N. Van Rooijen,et al.  Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. , 2006, The Journal of clinical investigation.

[85]  K. Kisich,et al.  The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. , 2005, American Journal of Respiratory and Critical Care Medicine.

[86]  R. V. Omkumar,et al.  Growth of gold nanoparticles in human cells. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[87]  K. Gordon,et al.  The tumour necrosis factor‐α inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques , 2005, The British journal of dermatology.

[88]  H. Hönigsmann,et al.  Review of the potential photo‐cocarcinogenicity of topical calcineurin inhibitors , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[89]  L. Naldi,et al.  Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. , 2005, The Journal of investigative dermatology.

[90]  D. Turnbull,et al.  The antipsoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  D. Gladman,et al.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.

[92]  C. Griffiths,et al.  Psoriasis: epidemiology, clinical features, and quality of life , 2005, Annals of the rheumatic diseases.

[93]  M. Schmid-Wendtner,et al.  Ultrasound scanning in dermatology. , 2005, Archives of dermatology.

[94]  A. Gottlieb,et al.  A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. , 2004, The Journal of investigative dermatology.

[95]  A. Gottlieb.  Etanercept for the treatment of psoriasis and psoriatic arthritis , 2004, Dermatologic therapy.

[96]  H. Lui,et al.  Incorporating Biologics into the Treatment of Psoriasis , 2004, Journal of cutaneous medicine and surgery.

[97]  S. Feldman,et al.  A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. , 2004, Journal of the American Academy of Dermatology.

[98]  M. Dhodapkar,et al.  Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.

[99]  S. Gordon,et al.  Dectin-1 Expression and Function Are Enhanced on Alternatively Activated and GM-CSF-Treated Macrophages and Are Negatively Regulated by IL-10, Dexamethasone, and Lipopolysaccharide 1 , 2003, The Journal of Immunology.

[100]  S. Yeo,et al.  Preparation of nanocomposite fibers for permanent antibacterial effect , 2003 .

[101]  E. Morelli,et al.  Characterization of cadmium- and lead- phytochelatin complexes formed in a marine microalga in response to metal exposure , 2002, Biometals.

[102]  D. West,et al.  Biologic therapy for psoriasis: the new therapeutic frontier. , 2002, Archives of dermatology.

[103]  James T. Elder,et al.  The genetics of psoriasis 2001: the odyssey continues. , 2001, Archives of dermatology.

[104]  E. Christophers.  Psoriasis − epidemiology and clinical spectrum , 2001, Clinical and experimental dermatology.

[105]  M. Lebwohl.  The role of salicylic acid in the treatment of psoriasis , 1999, International journal of dermatology.

[106]  N. Yawalkar,et al.  Expression of interleukin-12 is increased in psoriatic skin. , 1998, The Journal of investigative dermatology.

[107]  D. Gladman,et al.  Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. , 1997, Arthritis and rheumatism.

[108]  S. Goerdt,et al.  Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1± 25F9−) in psoriatic dermis , 1996, Archives of Dermatological Research.

[109]  T. Shiohara,et al.  Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption. , 1994, The American journal of pathology.

[110]  M. Feldmann,et al.  Localization of tumour necrosis factor‐alpha (TNF‐α) and its receptors in normal and psoriatic skin: epidermal cells express the 55‐kD but not the 75‐kD TNF receptor , 1993, Clinical and experimental immunology.

[111]  M. Rapaport,et al.  Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. , 1986, Journal of the American Academy of Dermatology.

[112]  H. Hönigsmann,et al.  Phototesting and dosimetry for photochemotherapy , 1977, The British journal of dermatology.

[113]  M. Gooderham,et al.  Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2). , 2016, Journal of the American Academy of Dermatology.

[114]  Xiao Ying Xu,et al.  Toxicity of metal oxide nanoparticles: mechanisms, characterization, and avoiding experimental artefacts. , 2015, Small.

[115]  A. Armstrong,et al.  Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. , 2013, JAMA dermatology.

[116]  S. Alarifi,et al.  Reactive Oxygen Species-Mediated DNA Damage and Apoptosis in Human Skin Epidermal Cells After Exposure to Nickel Nanoparticles , 2013, Biological Trace Element Research.

[117]  V. Patravale,et al.  Psoriasis clinical implications and treatment: a review. , 2013, Critical reviews in therapeutic drug carrier systems.

[118]  Peter Sonnenreich.  American academy of dermatology. , 2012, P & T : a peer-reviewed journal for formulary management.

[119]  Kui-jae Lee,et al.  Pine cone-mediated green synthesis of silver nanoparticles and their antibacterial activity against agricultural pathogens , 2012, Applied Microbiology and Biotechnology.

[120]  J. Kjems,et al.  Chitosan/siRNA Nanoparticle-mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[121]  Sudhir Gupta,et al.  Molecular mechanisms of TNF-alpha-induced apoptosis in aging human T cell subsets. , 2005, The international journal of biochemistry & cell biology.

[122]  F. Baldi,et al.  Bone mineral density in patients with psoriatic arthritis. , 2001, The Journal of rheumatology.

[123]  C. Bogdan,et al.  LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. , 2000, Blood.

[124]  J. J. van den Oord,et al.  Epithelium-lining macrophages in psoriasis. , 1994, The British journal of dermatology.

[125]  T Fredriksson,et al.  Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.

[126]  W. Eyler,et al.  PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.